CaMKK2 regulates cellular proliferation and androgen receptor activity during prostate cancer progression

被引：0
|
作者：
Karacosta, Loukia Georgiou [1 ]
Foster, Barbara A. [2 ]
Azabdaftari, Gissou [3 ]
Feliciano, David M. [4 ]
Edelman, Arthur M. [1 ]
机构：
[1] SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14260 USA
[2] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA
[3] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA
[4] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT USA
来源：
FASEB JOURNAL | 2012年 / 26卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Contribution of the Androgen Receptor to Prostate Cancer Predisposition and Progression
    Grant Buchanan
    Ryan A. Irvine
    Gerhard A. Coetzee
    Wayne D. Tilley
    Cancer and Metastasis Reviews, 2001, 20 : 207 - 223
  • [42] Modulation of cytokeratin subtype, EGF receptor, and androgen receptor expression during progression of prostate cancer
    de Medina, SGD
    Salomon, L
    Colombel, M
    Abbou, CC
    Bellot, J
    Thiery, JP
    Radvanyi, F
    Van der Kwast, TH
    Chopin, DK
    HUMAN PATHOLOGY, 1998, 29 (09) : 1005 - 1012
  • [43] GLUT12 promotes prostate cancer cell growth and is regulated by androgens and CaMKK2 signaling
    White, Mark A.
    Tsouko, Efrosini
    Lin, Chenchu
    Rajapakshe, Kimal
    Spencer, Jeffrey M.
    Wilkenfeld, Sandi R.
    Vakili, Sheiva S.
    Pulliam, Thomas L.
    Awad, Dominik
    Nikolos, Fotis
    Katreddy, Rajasekhara Reddy
    Kaipparettu, Benny Abraham
    Sreekumar, Arun
    Zhang, Xiaoliu
    Cheung, Edwin
    Coarfa, Cristian
    Frigo, Daniel E.
    ENDOCRINE-RELATED CANCER, 2018, 25 (04) : 453 - 469
  • [44] Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth
    Culig, Z
    Bartsch, G
    Hobisch, A
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2002, 197 (1-2) : 231 - 238
  • [45] Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival
    Y Wang
    M Mikhailova
    S Bose
    C-X Pan
    R W deVere White
    P M Ghosh
    Oncogene, 2008, 27 : 7106 - 7117
  • [46] Prognostic significance of neuroendocrine differentiation, proliferation activity and androgen receptor expression in prostate cancer
    Segawa, N
    Mori, I
    Utsunomiya, H
    Nakamura, M
    Nakamura, Y
    Shan, L
    Kakudo, K
    Katsuoka, Y
    PATHOLOGY INTERNATIONAL, 2001, 51 (06) : 452 - 459
  • [47] Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival
    Wang, Y.
    Mikhailova, M.
    Bose, S.
    Pan, C-X
    White, Rw deVere
    Ghosh, P. M.
    ONCOGENE, 2008, 27 (56) : 7106 - 7117
  • [48] NO-mediated inhibition of androgen receptor activity: Possible implications for prostate cancer progression
    Kroencke, KD
    Ince, Y
    Sies, H
    Weidemann, W
    Cronauer, M
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2006, 14 (04): : A40 - A40
  • [49] Topoisomerase 2 Alpha Cooperates with Androgen Receptor to Contribute to Prostate Cancer Progression
    Schaefer-Klein, J. L.
    Murphy, Stephen J.
    Johnson, Sarah H.
    Vasmatzis, George
    Kovtun, Irina V.
    PLOS ONE, 2015, 10 (11):
  • [50] CtBP2 Modulates the Androgen Receptor to Promote Prostate Cancer Progression
    Takayama, Ken-ichi
    Suzuki, Takashi
    Fujimura, Tetsuya
    Urano, Tomohiko
    Takahashi, Satoru
    Homma, Yukio
    Inoue, Satoshi
    CANCER RESEARCH, 2014, 74 (22) : 6542 - 6553
12345